Physician profile
Laura Cordes
NPI 1609860998
$15,964.86
in general payments reported to CMS, 2019-2025
28 companies · $352 in 2025
The $352 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $144 · 2020: $66.03 · 2021: $10K · 2022: $4,831 · 2023: $158 · 2024: $361 · 2025: $352.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $871.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $871.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $14,317.55 | 2021-2022 | |
| Abbvie INC. | $523.98 | 2019-2025 | Liletta |
| Astellas Pharma US INC | $184.52 | 2024-2025 | Veozah |
| Hologic Sales and Service, LLC | $109.22 | 2025 | Sonata Sonography-Guided Transcervical Fibroid Ablation System, Acessa Provu System |
| Biogen, INC. | $100.00 | 2025 | Zurzuvae |
| Pfizer INC. | $85.60 | 2019-2023 | |
| Daiichi Sankyo INC. | $68.69 | 2021-2024 | Injectafer |
| Sumitomo Pharma America, INC. | $60.01 | 2023-2024 | Myfembree |
| Bayer Healthcare Pharmaceuticals INC. | $58.55 | 2022-2025 | |
| Minerva Surgical, INC | $50.86 | 2022-2023 | |
| Organon LLC | $39.72 | 2021-2024 | |
| Novo Nordisk INC | $38.78 | 2019-2023 | |
| Coopersurgical, INC. | $36.40 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $35.48 | 2024 | Xarelto |
| Meditrina | $23.84 | 2024 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceuticals, INC. | $23.70 | 2021 | |
| Aspira Women'S Health INC | $23.47 | 2022 | |
| Stryker Corporation | $23.20 | 2025 | Clottriever Bold Catheter |
| Therapeuticsmd, INC. | $22.02 | 2021 | |
| Medtronic USA, INC. | $18.65 | 2020 | |
| Myovant Sciences INC. | $17.41 | 2022 | |
| Amgen INC. | $16.64 | 2025 | Prolia, Evenity |
| Mycovia Pharmaceuticals, INC. | $16.44 | 2023 | Vivjoa |
| Sanara Medtech INC. | $16.40 | 2025 | Celleraterx |
| Teleflex LLC | $15.88 | 2021 | |
| Amag Pharmaceuticals, INC. | $13.74 | 2019 | |
| Smith+Nephew, INC. | $12.13 | 2019 | |
| Lupin INC. | $11.98 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Laura Cordes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.